FDA FAERS pharmacovigilance study of MSK serious adverse reports w/ GLP-1 RAs - Muscle atrophy showed the strongest AE, w/ less freq reports of back pain, muscle spasms, neck pain. https://t.co/4xRH6yWH1o https://t.co/MKCKtkFd1u
Links:
Musculoskeletal Adverse Event Signals Associated With Semaglutide, Liraglutide,…
https://buff.ly/7bAa0wv
Sep-25-2026
